About Us

Committees

CGPA EXECUTIVE COMMITTEE
Doug Sommerville, Chair Teva
Jean-Guy Goulet, Vice-Chair Pharmascience
Jeremy Desai Apotex
Peter Hardwick Apotex
Jack Kay Apotex
Jeff Watson Apotex
Barry Hayter Mylan
David Goodman Pharmascience
Morris Goodman Pharmascience
Michel Robidoux Sandoz
Barb Pimentel Taro

 

Intellectual Property Committee

This committee provides advice to CGPA on issues related to Canada’s pharmaceutical patent regime.
Chair: Kevin Zive, Apotex
Vice-Chair: Shona Mcdiarmid, Pharmascience

 

Market Growth Committee

This committee develops strategies to facilitate the increase in generic pharmaceutical sales in Canada and internationally. This group benchmarks international practices and develops options for companies to increase private sector market share.
Chair: Heather J. West, Apotex
Vice-Chair: Houri Ohan, Teva

 

Government Relations Committee

The committee assists CGPA in its communications with all levels of government.
Chair: Gayle Peddle, Taro
Vice-Chair: Nicole Neveu, Pharmascience

 

Scientific Affairs Committee

This committee is responsible for liaising with, and providing input to, Health Canada on various scientific issues related to the approval of generic pharmaceuticals at the federal level.
Chair: Len Arsenault, Sandoz
Vice-Chair: Mathi Mathivanan, Teva

 

Industry Practices Review Board – Quebec

This board is responsible for the education, compliance and enforcement activities required for the implementation of CGPA’s code of marketing conduct in Quebec.